Citigroup (C) stock rises 2.0% in premarket trading after Barclays upgrades to Overweight, predicting accelerated earnings growth and positive operating leverage.
BlackRock (NYSE:BLK) stock closed with a 5.2% gain after the company reported a strong fourth quarter for 2024, surpassing expectations largely due to performance fees, managed expenses, and a favorable tax rate.
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news analysis firm, with a 30-year track record and clients globally. We take pride in covering 400+ technology vendors globally – the largest by any analyst firm in this space.
Citigroup Inc (C) stock saw a modest uptick, ending the day at $73.68 which represents a slight increase of $0.94 or 1.29% from the prior close of $72.74. The stock opened at $73.9 and touched a low of $72.
Southwest Airlines (LUV – Research Report) received a Sell rating and a price target from Citi analyst Stephen Trent yesterday. The company’s
Unsurprisingly in this context, both Barclays and Citi continue to recommend buying Atlassian shares, which Barclays thinks are worth $275 a share and Citi values at $255. But here's the thing ...
Validis, a market leader in financial data collection and standardization, today announced strategic investments from Citi and Barclays.
In a report released on January 16, Cecilia Romero from Barclays maintained a Hold rating on CAIXABANK (0ILK – Research Report), with a price
Validis, a market leader in financial data collection and standardization, today announced strategic investments from Citi and Barclays. The announcement marks a milestone in furthering efforts to modernize business lending through automated data standardization,
Citi analyst Thomas Palmer maintained a Hold rating on McCormick & Company (MKC – Research Report) today. The company’s shares closed
Barclays analyst Brandon Oglenski maintained a Hold rating on Southwest Airlines (LUV – Research Report) today and set a price target of
JPMorgan Chase & Co. (NYSE:JPM) had its target price upped by investment analysts at Barclays from $304.00 to $330.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the financial services provider’s stock.